CHECKPOINT THERAPEUTICS

Checkpoint Therapeutics, a Fortress Biotech Company, is an immuno-oncology biopharmaceutical company focused on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. They aim to acquire rights to these technologies by licensing the rights or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market.